Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-11-08
1997-03-18
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483331, 514913, A61K 31415
Patent
active
056123647
ABSTRACT:
Compositions containing, and methods for controlling intraocular pressure with, substantially pure apraclonidine are disclosed.
REFERENCES:
patent: 4517199 (1985-05-01), York et al.
patent: 5212196 (1993-05-01), House et al.
Physicians' Desk Reference, Product Information, Iopidine.RTM., 23rd Edition, 219-220 (1995).
Physicians' Desk Reference, Product Information, Iopidine.RTM. 0.5%, 23rd Edition, 219-220 (1995).
DuPriest Mark T.
Yanni John M.
York Billie M.
Alcon Laboratories Inc.
Morris Patricia L.
Yeager Sally
LandOfFree
Substantially pure apraclonidine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substantially pure apraclonidine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substantially pure apraclonidine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1706651